Showing results (641-650 of 1,191) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|April 10, 2014
A randomized phase I Bayesian dose escalation design for the combination of anti-cancer drugsDavid Dejardin, Emmanuel Lesaffre, Paul Hamberg, et al.Pharmaceutical Statistics|February 14, 2014
Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcomeMarco Munda, Catherine LegrandPharmaceutical Statistics|February 24, 2017
Probability of success for phase III after exploratory biomarker analysis in phase IIHeiko Götte, Marietta Kirchner, Martin Oliver SailerPharmaceutical Statistics|October 7, 2022
Treatment effect measures under nonproportional hazardsSteven Snapinn, Qi Jiang, Chunlei KePharmaceutical Statistics|February 17, 2021
Statistical considerations in clinical trial design with event-free survival as the primary efficacy endpointTu Xu, Yiming Zhang, Meredith Goldwasser, et al.Pharmaceutical Statistics|February 18, 2021
A robust permutation test for the concordance correlation coefficientAlan D Hutson, Han YuPharmaceutical Statistics|October 23, 2018
Blinded continuous monitoring in clinical trials with recurrent event endpointsTim Friede, Dieter A Häring, Heinz SchmidliPharmaceutical Statistics|November 1, 2018
How can we make better graphs? An initiative to increase the graphical expertise and productivity of quantitative scientistsMarc Vandemeulebroecke, Mark Baillie, David Carr, et al.Pharmaceutical Statistics|December 22, 2021
A targeted simulation-extrapolation method for evaluating biomarkers based on new technologies in precision medicineDong Wang, Sue-Jane Wang, Joshua Xu, et al.Pharmaceutical Statistics|March 3, 2017
A Bayesian sequential design with binary outcomeHan Zhu, Qingzhao Yu, Donald E MercantePageof 120